Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience-Reference-Cited by-同舟云学术

Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience

Published:2016-02 Issue:2 Volume:17 Page:113-121
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Tong Myron John¹²,Chang Patrick Weijen¹,Huynh Thatcher Thi¹,Rosinski Alexander Anthony¹,Tong Lori Terese¹

Affiliation:

1. Liver Center; Huntington Medical Research Institutes; Pasadena

2. Pfleger Liver Institute and the Division of Digestive Diseases; David Geffen School of Medicine; University of California; Los Angeles California USA

Publisher

Wiley

Subject

Gastroenterology

Reference30 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

2. Systematic review: Asian patients with chronic hepatitis C infection;Nguyen;Aliment Pharmacol Ther,2013

3. Epidemiology of hepatitis C virus infection;Alter;World J Gastroenterol,2007

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials;Hepatology Research;2020-08-11

2. Predictors of adverse drug reactions associated with ribavirin in direct‐acting antiviral therapies for chronic hepatitis C;Pharmacoepidemiology and Drug Safety;2019-11-06

3. Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World;Journal of Managed Care & Specialty Pharmacy;2019-06

4. Sofosbuvir induced leucocytoclasic vasculitis: a case report;BMC Dermatology;2019-05-17

5. Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection;Liver International;2018-06-29